ArticleThe Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology2026
Anemia and long-term outcomes after second-generation drug-eluting stent implantation: a retrospective cohort study of mortality and clinical restenosis.
Article in The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAnemia is common in patients undergoing percutaneous coronary intervention (PCI) and is a well-established predictor of bleeding and mortality. However, whether anemia contributes to clinically relevant in-stent restenosis (ISR) in the era of second-generation drug-eluting stents (DES) and competing long-term risks remains uncertain.
methodsWe retrospectively analyzed 4,117 consecutive adults treated with PCI using second-generation DES at Tehran Heart Center. Anemia was defined as hemoglobin <13 g/dL in men and < 12 g/dL in women. The prespecified primary endpoint was clinically driven target lesion revascularization (TLR) within 5 years, used as a pragmatic proxy for clinical ISR and requiring ischemic symptoms or objective ischemia attributable to the index lesion. Secondary endpoints included all-cause mortality and major adverse cardiac and cerebrovascular events (MACCE). Associations between anemia and outcomes were estimated using Cox proportional hazards models with inverse probability weighting (IPW) based on baseline covariates; Fine-Gray competing-risk models treating death as a competing event were prespecified sensitivity analyses for TLR.
resultsAnemia was present in 369/4,117 (9.0%) patients. Cumulative TLR occurred in 73 (1.9%) patients, with only 3 events in the anemic group. Given this low event rate, statistical power to detect a difference in TLR was limited. TLR rates did not differ significantly between groups (IPW-adjusted HR 0.27, 95% CI 0.07 to 1.01; p = 0.051), a finding that was consistent in competing-risk analyses. In contrast, mortality was significantly higher in anemic patients (11.5% vs. 4.6%; IPW-adjusted HR 1.87, 95% CI 1.22 to 2.87; p = 0.004).
conclusionsIn an all-comers cohort undergoing PCI with second-generation DES, baseline anemia was not associated with an increased risk of clinically driven TLR, but it remained a strong independent predictor of long-term mortality. These findings suggest that in contemporary practice, the dominant prognostic impact of anemia is on mortality. However, given the low TLR event rate, the relationship between anemia and clinically manifest restenosis requires further investigation in larger, adequately powered studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.